sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Immunoglobulin Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre syndrome, and Others), Product Type (IgG, IgA, IgM, IgE, and IgD), and by Mode of Delivery (Intravenous [5%, 10%, and Other Concentrations] and Subcutaneous [16.5%, 20%, and Other Concentrations]) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Immunoglobulin Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency...

Home / Categories / Healthcare
Immunoglobulin Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre syndrome, and Others), Product Type (IgG, IgA, IgM, IgE, and IgD), and by Mode of Delivery (Intravenous [5%, 10%, and Other Concentrations] and Subcutaneous [16.5%, 20%, and Other Concentrations]) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Immunoglobulin Market by Application (Hypogammaglobulinemia,...
Report Code
RO1/113/1221

Publish Date
26/Nov/2024

Pages
220
PRICE
$ 5540/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 6654/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 9280/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
TABLE 1. COMMERCIALIZED IMMUNOGLOBULIN PRODUCTS
TABLE 2. BASELINE IMMUNOGLOBULIN YEARLY COSTS (2009)
TABLE 3. U.S. FDA INDICATIONS FOR IMMUNOGLOBULIN
TABLE 4. EMA-APPROVED INDICATIONS FOR IMMUNOGLOBULIN
TABLE 5. IGG SUBCLASS
TABLE 6. FREQUENCY (%) OF DECREASED IGG SUBCLASS CONCENTRATION IN ADULTS
TABLE 7. DISEASES ASSOCIATED WITH IGG SUBCLASS DEFICIENCY
TABLE 8. CLINICAL TRIALS FOR IMMUNOGLOBULIN (2015-2016)
TABLE 9. GLOBAL IMMUNOGLOBULIN MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL IMMUNOGLOBULIN MARKET, BY APPLICATION, 2016-2023 (KILOGRAM)
TABLE 11. COMMON MEDICATION FOR THE HYPOGAMMAGLOBULINEMIA ASSOCIATED WITH RECURRENT BACTERIAL INFECTIONS
TABLE 12. GLOBAL IMMUNOGLOBULIN MARKET FOR HYPOGAMMAGLOBULINEMIA, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 13. GLOBAL IMMUNOGLOBULIN MARKET FOR CIDP, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 14. PRINCIPLE OF IMMUNOGLOBULIN THERAPY IN IMMUNODEFICIENCY
TABLE 15. GLOBAL IMMUNOGLOBULIN MARKET FOR PRIMARY IMMUNODEFICIENCY DISEASE, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 16. GLOBAL IMMUNOGLOBULIN MARKET FOR MYASTHENIA GRAVIS, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 17. GLOBAL IMMUNOGLOBULIN MARKET FOR MMN, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 18. ITP TREATMENT OPTIONS
TABLE 19. GLOBAL IMMUNOGLOBULIN MARKET FOR PRIMARY ITP, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 20. GLOBAL IMMUNOGLOBULIN MARKET FOR INFLAMMATORY MYOPATHY, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 21. GLOBAL IMMUNOGLOBULIN MARKET FOR SAD, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 22. GLOBAL IMMUNOGLOBULIN MARKET FOR GBS, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 23. GLOBAL IMMUNOGLOBULIN MARKET FOR OTHERS, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 24. GLOBAL IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, 2016-2023 ($MILLION)
TABLE 25. GLOBAL IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, 2016-2023 (KILOGRAM)
TABLE 26. GLOBAL IMMUNOGLOBULIN MARKET FOR INTRAVENOUS MODE OF DELIVERY, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 27. GLOBAL IVIG MARKET FOR 5% CONCENTRATION, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 28. GLOBAL IVIG MARKET FOR 10% CONCENTRATION, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 29. GLOBAL IVIG MARKET FOR OTHER CONCENTRATIONS, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 30. GLOBAL SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 31. GLOBAL SCIG MARKET FOR 16.5% CONCENTRATION, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 32. GLOBAL SCIG MARKET FOR 20% CONCENTRATION, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 33. GLOBAL SCIG MARKET FOR OTHER CONCENTRATIONS, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 34. IMMUNOGLOBULIN MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 35. IMMUNOGLOBULIN MARKET, BY GEOGRAPHY, 2016-2023 (KILOGRAM)
TABLE 36. NORTH AMERICA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION & KILOGRAM)
TABLE 37. NORTH AMERICA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 38. NORTH AMERICA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 39. U.S. IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 40. U.S. IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 41. U.S. SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 42. CANADA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 43. CANADA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 44. CANADA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 45. MEXICO IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 46. MEXICO IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 47. MEXICO SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 48. EUROPE IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION & KILOGRAM)
TABLE 49. EUROPE IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 50. EUROPE SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 51. UK IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 52. UK IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 53. UK SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 54. FRANCE IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 55. FRANCE IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 56. FRANCE SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 57. GERMANY IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 58. GERMANY IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 59. GERMANY SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 60. ITALY IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 61. ITALY IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 62. ITALY SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 63. AUSTRIA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 64. AUSTRIA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 65. AUSTRIA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 66. RUSSIA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 67. RUSSIA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 68. RUSSIA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 69. REST OF EUROPE IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 70. REST OF EUROPE IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 71. REST OF EUROPE SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 72. ASIA-PACIFIC IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION & KILOGRAM)
TABLE 73. ASIA-PACIFIC IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 74. ASIA-PACIFIC SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 75. AUSTRALIA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 76. AUSTRALIA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 77. AUSTRALIA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 78. CHINA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 79. CHINA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 80. CHINA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 81. JAPAN IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 82. JAPAN IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 83. JAPAN SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 84. INDIA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 85. INDIA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 86. INDIA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 87. REST OF ASIA-PACIFIC IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 88. REST OF ASIA-PACIFIC IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 89. REST OF ASIA-PACIFIC SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 90. LAMEA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION & KILOGRAM)
TABLE 91. LAMEA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 92. LAMEA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 93. BRAZIL IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 94. BRAZIL IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 95. BRAZIL SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 96. ARGENTINA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 97. ARGENTINA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 98. ARGENTINA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 99. TURKEY IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 100. TURKEY IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 101. TURKEY SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 102. SAUDI ARABIA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 103. SAUDI ARABIA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 104. SAUDI ARABIA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 105. REST OF LAMEA IMMUNOGLOBULIN MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 106. REST OF LAMEA IVIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 107. REST OF LAMEA SCIG MARKET, 2016-2023 ($MILLION AND KILOGRAM)
TABLE 108. BAXTER: COMPANY SNAPSHOT
TABLE 109. BAXTER: OPERATING SEGMENTS
TABLE 110. BAXTER: PRODUCT PORTFOLIO
TABLE 111. CSL: COMPANY SNAPSHOT
TABLE 112. CSL: OPERATING SEGMENTS
TABLE 113. GRIFOLS: COMPANY SNAPSHOT
TABLE 114. GRIFOLS: OPERATING SEGMENTS
TABLE 115. GRIFOLS: PRODUCT PORTFOLIO
TABLE 116. OCTAPHARMA: COMPANY SNAPSHOT
TABLE 117. OCTAPHARMA: OPERATING SEGMENTS
TABLE 118. KEDRION: COMPANY SNAPSHOT
TABLE 119. KEDRION: OPERATING SEGMENTS
TABLE 120. KEDRION: PRODUCT PORTFOLIO
TABLE 121. LFB: COMPANY SNAPSHOT
TABLE 122. LFB: OPERATING SEGMENTS
TABLE 123. BIOTEST: COMPANY SNAPSHOT
TABLE 124. BIOTEST: OPERATING SEGMENTS
TABLE 125. BIOTEST: PRODUCT PORTFOLIO
TABLE 126. CHINA BIOLOGICS PRODUCTS: COMPANY SNAPSHOT
TABLE 127. CHINA BIOLOGICS PRODUCTS: OPERATING SEGMENTS
TABLE 128. CHINA BIOLOGICS PRODUCTS: PRODUCT PORTFOLIO
TABLE 129. BDI: COMPANY SNAPSHOT
TABLE 130. BDI: PRODUCT PORTFOLIO
TABLE 131. BAYER: COMPANY SNAPSHOT
TABLE 132. BAYER: OPERATING SEGMENTS
TABLE 133. BAYER: PRODUCT PORTFOLIO
LIST OF FIGURE
FIGURE 1. MARKET SEGMENTATION
FIGURE 2. PERCENTAGE SHARE OF COST ASSOCIATED WITH SIDE EFFECTS INDUCED BY IMMUNOGLOBULIN THERAPY
FIGURE 3. TOP IMPACTING FACTORS, 2016-2023
FIGURE 4. TOP INVESTMENT POCKETS
FIGURE 5. BARGAINING POWER OF BUYERS
FIGURE 6. BARGAINING POWER OF SUPPLIERS
FIGURE 7. THREAT OF NEW ENTRANTS
FIGURE 8. THREAT OF SUBSTITUTION
FIGURE 9. COMPETITIVE RIVALRY
FIGURE 10. VALUE CHAIN ANALYSIS
FIGURE 11. MARKET SHARE ANALYSIS, 2016
FIGURE 12. BAXTER: REVENUE, 2014-2016 ($MILLION)
FIGURE 13. BAXTER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 14. CSL: REVENUE, 2014-2016 ($MILLION)
FIGURE 15. CSL: REVENUE BY SEGMENT, 2016 (%)
FIGURE 16. GRIFOLS: REVENUE, 2014-2016 ($MILLION)
FIGURE 17. GRIFOLS: REVENUE SHARE BY PRODUCT TYPE, 2016 (%)
FIGURE 18. GRIFOLS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 19. OCTAPHARMA: REVENUE, 2014-2016 ($MILLION)
FIGURE 20. OCTAPHARMA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 21. OCTAPHARMA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 22. KEDRION: REVENUE, 2014-2016 ($MILLION)
FIGURE 23. KEDRION: REVENUE BY SEGMENT, 2016 (%)
FIGURE 24. KEDRION: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 25. LFB: REVENUE, 2014-2016 ($MILLION)
FIGURE 26. LFB: REVENUE SHARE BY GEOGRAPHY, 2015 (%)
FIGURE 27. BIOTEST: REVENUE, 2014-2016 ($MILLION)
FIGURE 28. BIOTEST: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 29. BIOTEST: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 30. CHINA BIOLOGICS PRODUCTS: REVENUE, 2014-2016 ($MILLION)
FIGURE 31. CHINA BIOLOGICS PRODUCTS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 32. CHINA BIOLOGICS PRODUCTS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 33. BDI: REVENUE, 2014-2016 ($MILLION)
FIGURE 34. BDI: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 35. BDI: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 36. BAYER: REVENUE, 2014-2016 ($MILLION)
FIGURE 37. BAYER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 38. BAYER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com